Enzo Biochem (NYSE:ENZ) Announces Quarterly Earnings Results

Enzo Biochem (NYSE:ENZ) released its earnings results on Monday. The medical research company reported ($0.05) EPS for the quarter, Zacks reports. Enzo Biochem had a negative return on equity of 11.84% and a negative net margin of 81.73%.

Enzo Biochem Stock Performance

NYSE:ENZ opened at $0.70 on Wednesday. The business has a 50 day simple moving average of $1.09 and a 200 day simple moving average of $1.11. Enzo Biochem has a 12-month low of $0.68 and a 12-month high of $1.50.

Enzo Biochem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Friday, November 15th were given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 57.14%. The ex-dividend date of this dividend was Friday, November 15th.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of Enzo Biochem in a report on Tuesday. They issued a “hold” rating for the company.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.